ARTICLE | Company News
FDA accepts ANDA for generic Depakote
March 3, 2000 8:00 AM UTC
The FDA accepted for filing an ANDA from Andrx (ADRX) for a bioequivalent version of Depakote divalproex to treat epilepsy. Depakote is marketed by Abbott (ABT), which reported 1999 U.S. sales of near...